These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 27098123)
1. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH. Gründker C; Bauerschmitz G; Schubert A; Emons G Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10. Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751 [TBL] [Abstract][Full Text] [Related]
3. S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2. Xu H; Li M; Zhou Y; Wang F; Li X; Wang L; Fan Q Tumour Biol; 2016 Mar; 37(3):2925-32. PubMed ID: 26409452 [TBL] [Abstract][Full Text] [Related]
4. Baicalein Inhibits Epithelial to Mesenchymal Transition via Downregulation of Cyr61 and LOXL-2 in MDA-MB231 Breast Cancer Cells. Nguyen LT; Song YW; Cho SK Mol Cells; 2016 Dec; 39(12):909-914. PubMed ID: 28008161 [TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231. Aguilar-Rojas A; Huerta-Reyes M; Maya-Núñez G; Arechavaleta-Velásco F; Conn PM; Ulloa-Aguirre A; Valdés J BMC Cancer; 2012 Nov; 12():550. PubMed ID: 23176180 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion. Hellinger JW; Hüchel S; Goetz L; Bauerschmitz G; Emons G; Gründker C Front Oncol; 2019; 9():1074. PubMed ID: 31709177 [No Abstract] [Full Text] [Related]
7. miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61. Huang Y; Zhang J; Shao H; Liu J; Jin M; Chen J; Zhao H Cell Physiol Biochem; 2018; 51(2):938-948. PubMed ID: 30466075 [TBL] [Abstract][Full Text] [Related]
8. S100A4 hypomethylation affects epithelial-mesenchymal transition partially induced by LMP2A in nasopharyngeal carcinoma. Lin Z; Deng L; Ji J; Cheng C; Wan X; Jiang R; Tang J; Zhuo H; Sun B; Chen Y Mol Carcinog; 2016 Oct; 55(10):1467-76. PubMed ID: 26292668 [TBL] [Abstract][Full Text] [Related]
9. miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4. He Z; Yu L; Luo S; Li M; Li J; Li Q; Sun Y; Wang C BMC Cancer; 2017 Feb; 17(1):140. PubMed ID: 28209128 [TBL] [Abstract][Full Text] [Related]
10. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis. Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269 [TBL] [Abstract][Full Text] [Related]
11. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells. Radestock Y; Hoang-Vu C; Hombach-Klonisch S Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015 [TBL] [Abstract][Full Text] [Related]
12. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13. Wang L; Wang X; Liang Y; Diao X; Chen Q Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804 [TBL] [Abstract][Full Text] [Related]
13. Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer. Huang X; Xiang L; Li Y; Zhao Y; Zhu H; Xiao Y; Liu M; Wu X; Wang Z; Jiang P; Qing H; Zhang Q; Liu G; Zhang W; Li A; Chen Y; Liu S; Wang J Cell Physiol Biochem; 2018; 47(2):590-603. PubMed ID: 29794466 [TBL] [Abstract][Full Text] [Related]
14. IGF-1 regulates Cyr61 induced breast cancer cell proliferation and invasion. Sarkissyan S; Sarkissyan M; Wu Y; Cardenas J; Koeffler HP; Vadgama JV PLoS One; 2014; 9(7):e103534. PubMed ID: 25062088 [TBL] [Abstract][Full Text] [Related]
15. Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells. Lee Y; Jung WH; Koo JS Breast Cancer Res Treat; 2015 Sep; 153(2):323-35. PubMed ID: 26285644 [TBL] [Abstract][Full Text] [Related]
16. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation. Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839 [TBL] [Abstract][Full Text] [Related]
17. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line. Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370 [TBL] [Abstract][Full Text] [Related]
18. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression. Schubert A; Schulz H; Emons G; Gründker C Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413 [TBL] [Abstract][Full Text] [Related]
19. The role of S100A4 for bone metastasis in prostate cancer cells. Kim B; Jung S; Kim H; Kwon JO; Song MK; Kim MK; Kim HJ; Kim HH BMC Cancer; 2021 Feb; 21(1):137. PubMed ID: 33549040 [TBL] [Abstract][Full Text] [Related]
20. Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells. Chin LH; Hsu SP; Zhong WB; Liang YC Mol Carcinog; 2016 May; 55(5):622-32. PubMed ID: 25773758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]